Patient optimization for gastrointestinal cancer surgery

British Journal of Surgery

Volumn 100, Issue 1, 2013, Pages 15-27

  Fearon, K C ^a   Jenkins, J T ^b   Carli, F ^c   Lassen, K ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ANEMIA; COMORBIDITY; DIABETES MELLITUS; DISEASE FREE SURVIVAL; GASTROINTESTINAL TUMOR; HUMAN; KIDNEY FAILURE; METASTASIS; METHODOLOGY; MORTALITY; MUSCLE ATROPHY; NUTRITIONAL STATUS; PERIOPERATIVE PERIOD; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

ANEMIA; COMORBIDITY; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; GASTROINTESTINAL NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NUTRITIONAL STATUS; PERIOPERATIVE CARE; QUALITY OF LIFE; RENAL INSUFFICIENCY; RISK REDUCTION BEHAVIOR; SARCOPENIA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84870884325     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8988     Document Type: Review

References (143)

1. van Gijn W, Gooiker GA, Wouters MW, Post PN, Tollenaar RA, van de Velde CJ,. Volume and outcome in colorectal cancer surgery. Eur J Surg Oncol 2010; 36 (Suppl 1): S55-S63.
2. Baili P, Micheli A, De AR, Weir HK, Francisci S, Santaquilani M, et al.,; CONCORD Working Group. Life tables for world-wide comparison of relative survival for cancer (CONCORD study). Tumori 2008; 94: 658-668.
3. Akyol AM, McGregor JR, Galloway DJ, Murray GD, George WD,. Anastomotic leaks in colorectal cancer surgery: a risk factor for recurrence? Int J Colorectal Dis 1991; 6: 179-183.
4. Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P,. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg 2011; 253: 890-899.
5. Des GG, Nicolas P, Perret GY, Morere JF, Uzzan B,. Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer 2010; 46: 1049-1055.
6. Markar SR, Karthikesalingam A, Thrumurthy S, Ho A, Muallem G, Low DE,. Systematic review and pooled analysis assessing the association between elderly age and outcome following surgical resection of esophageal malignancy. Dis Esophagus 2012; [Epub ahead of print].
7. Varadhan KK, Neal KR, Dejong CH, Fearon KC, Ljungqvist O, Lobo DN,. The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials. Clin Nutr 2010; 29: 434-440.
8. Tseng WH, Yang X, Wang H, Martinez SR, Chen SL, Meyers FJ, et al., Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg 2011; 254: 333-338.
9. Kingham TP, Pachter HL,. Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg 2009; 208: 269-278.
10. Ansorge C, Strommer L, Andrén-Sandberg A, Lundell L, Herrington MK, Segersvard R,. Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy. Br J Surg 2012; 99: 1076-1082.
11. Fleming FJ, Pahlman L, Monson JR,. Neoadjuvant therapy in rectal cancer. Dis Colon Rectum 2011; 54: 901-912.
12. Vande WC, Ceelen WP, Boterberg T, Vande PD, Van NY, Varin O, et al., Anastomotic complications after Ivor Lewis esophagectomy in patients treated with neoadjuvant chemoradiation are related to radiation dose to the gastric fundus. Int J Radiat Oncol Biol Phys 2012; 82: e513-e519.
13. Mukherjee S, Aston D, Minett M, Brewster AE, Crosby TD,. The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers. Clin Oncol (R Coll Radiol) 2003; 15: 115-120.
14. Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA,. Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg 2012; 255: 237-247.
15. Awad S, Tan BH, Cui H, Bhalla A, Fearon KC, Parsons SL, et al., Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 2012; 31: 74-77.
16. Ferriolli E, Skipworth RJ, Hendry P, Scott A, Stensteth J, Dahele M, et al., Physical activity monitoring: a responsive and meaningful patient-centered outcome for surgery, chemotherapy, or radiotherapy? J Pain Symptom Manage 2012; 43: 1025-1035.
17. Ott K, Lordick F, Blank S, Buchler M,. Gastric cancer: surgery in 2011. Langenbecks Arch Surg 2011; 396: 743-758.
18. Copeland GP, Jones D, Walters M,. POSSUM: a scoring system for surgical audit. Br J Surg 1991; 78: 355-360.
19. Prytherch DR, Whiteley MS, Higgins B, Weaver PC, Prout WG, Powell SJ,. POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity. Br J Surg 1998; 85: 1217-1220.
20. Haga Y, Ikejiri K, Wada Y, Takahashi T, Ikenaga M, Akiyama N, et al., A multicenter prospective study of surgical audit systems. Ann Surg 2011; 253: 194-201.
21. Murphy MM, Tseng JF, Shah SA,. Disparities in cancer care: an operative perspective. Surgery 2010; 147: 733-737.
22. Murphy MM, Simons JP, Hill JS, McDade TP, Chau NS, Whalen GF, et al., Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma. Cancer 2009; 115: 3979-3990.
23. Bettelli G,. Preoperative evaluation in geriatric surgery: comorbidity, functional status and pharmacological history. Minerva Anestesiol 2011; 77: 637-646.
24. Bluman LG, Mosca L, Newman N, Simon DG,. Preoperative smoking habits and postoperative pulmonary complications. Chest 1998; 113: 883-889.
25. Tonnesen H, Kehlet H,. Preoperative alcoholism and postoperative morbidity. Br J Surg 1999; 86: 869-874.
26. Tonnesen H, Rosenberg J, Nielsen HJ, Rasmussen V, Hauge C, Pedersen IK, et al., Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ 1999; 318: 1311-1316.
27. Sorensen LT, Karlsmark T, Gottrup F,. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg 2003; 238: 1-5.
28. Lindstrom D, Sadr AO, Wladis A, Tonnesen H, Linder S, Nasell H, et al., Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg 2008; 248: 739-745.
29. Sørensen LT,. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg 2012; 255: 1069-1079.
30. Deboer MD,. Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention. Expert Rev Endocrinol Metab 2011; 6: 279-289.
31. Olsen NJ, Mortensen EL, Heitmann BL,. Predisposition to obesity: should we target those most susceptible? Curr Obes Rep 2012; 1: 35-41.
32. Gaujoux S, Torres J, Olson S, Winston C, Gonen M, Brennan MF, et al., Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol 2012; 19: 2908-2916.
33. Makino T, Shukla PJ, Rubino F, Milsom JW,. The impact of obesity on perioperative outcomes after laparoscopic colorectal resection. Ann Surg 2012; 255: 228-236.
34. Nobuoka D, Gotohda N, Kato Y, Takahashi S, Konishi M, Kinoshita T,. Influence of excess body weight on the surgical outcomes of total gastrectomy. Surg Today 2011; 41: 928-934.
35. Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R, et al., Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol 2011; 18: 2126-2135.
36. Tsai S, Choti MA, Assumpcao L, Cameron JL, Gleisner AL, Herman JM, et al., Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study. J Gastrointest Surg 2010; 14: 1143-1150.
37. Zhou Y, Wu L, Li X, Wu X, Li B,. Outcome of laparoscopic colorectal surgery in obese and nonobese patients: a meta-analysis. Surg Endosc 2012; 26: 783-789.
38. Windsor JA, Hill GL,. Protein depletion and surgical risk. Aust N Z J Surg 1988; 58: 711-715.
39. Hendry PO, Hausel J, Nygren J, Lassen K, Dejong CH, Ljungqvist O, et al.,; Enhanced Recovery After Surgery Study Group. Determinants of outcome after colorectal resection within an enhanced recovery programme. Br J Surg 2009; 96: 197-205.
40. Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE,. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012; 107: 931-936.
41. Ferguson MK, Durkin AE,. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002; 123: 661-669.
42. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al., Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-1049.
43. Gouin JP, Kiecolt-Glaser JK,. The impact of psychological stress on wound healing: methods and mechanisms. Immunol Allergy Clin North Am 2011; 31: 81-93.
44. Carli F, Charlebois P, Baldini G, Cachero O, Stein B,. An integrated multidisciplinary approach to implementation of a fast-track program for laparoscopic colorectal surgery. Can J Anaesth 2009; 56: 837-842.
45. Stergiopoulou A, Birbas K, Katostaras T, Mantas J,. The effect of interactive multimedia on preoperative knowledge and postoperative recovery of patients undergoing laparoscopic cholecystectomy. Methods Inf Med 2007; 46: 406-409.
46. Fearon KC, Ljungqvist O, Von Meyenfeldt M, Revhaug A, Dejong CH, Lassen K, et al., Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 2005; 24: 466-477.
47. Lassen K, Soop M, Nygren J, Cox PBW, Hendry PO, Spies C, et al.,; Enhanced Recovery After Surgery (ERAS) Group. Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. Arch Surg 2009; 144: 961-969.
48. Blamey SL, Fearon KC, Gilmour WH, Osborne DH, Carter DC,. Prediction of risk in biliary surgery. Br J Surg 1983; 70: 535-538.
49. Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ,. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002; 236: 17-27.
50. Saleh MM, Norregaard P, Jorgensen HL, Andersen PK, Matzen P,. Preoperative endoscopic stent placement before pancreaticoduodenectomy: a meta-analysis of the effect on morbidity and mortality. Gastrointest Endosc 2002; 56: 529-534.
51. Wang Q, Gurusamy KS, Lin H, Xie X, Wang C,. Preoperative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev 2008; (3)CD005444.
52. Qiu YD, Bai JL, Xu FG, Ding YT,. Effect of preoperative biliary drainage on malignant obstructive jaundice: a meta-analysis. World J Gastroenterol 2011; 17: 391-396.
53. Garcea G, Chee W, Ong SL, Maddern GJ,. Preoperative biliary drainage for distal obstruction: the case against revisited. Pancreas 2010; 39: 119-126.
54. van der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der HE, Kubben FJ, et al., Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 2010; 362: 129-137.
55. Chamogeorgakis T, Anagnostopoulos C, Kostopanagiotou G, Bhora F, Toumpoulis I, Georgiannakis E, et al., Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment? Thorac Cardiovasc Surg 2008; 56: 148-153.
56. Goodnough LT, Shander A, Spivak JL, Waters JH, Friedman AJ, Carson JL, et al., Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 2005; 101: 1858-1861.
57. Dionigi G, Rovera F, Boni L, Carrafiello G, Recaldini C, Mangini M, et al., The impact of perioperative blood transfusion on clinical outcomes in colorectal surgery. Surg Oncol 2007; 16 (Suppl 1): S177-S182.
58. Yeh JJ, Gonen M, Tomlinson JS, Idrees K, Brennan MF, Fong Y,. Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas. Br J Surg 2007; 94: 466-472.
59. Clark E, Connor S, Taylor MA, Hendry CL, Madhavan KK, Garden OJ, et al., Perioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma. HPB (Oxford) 2007; 9: 472-477.
60. Kwon AH, Matsui Y, Kamiyama Y,. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer 2001; 91: 771-778.
61. Kneuertz PJ, Patel SH, Chu CK, Maithel SK, Sarmiento JM, Delman KA, et al., Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol 2011; 18: 1327-1334.
62. Amato A, Pescatori M,. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006; (1)CD005033.
63. Busch OR, Hop WC, Marquet RL, Jeekel J,. The effect of blood transfusions on survival after surgery for colorectal cancer. Eur J Cancer 1995; 31A: 1226-1228.
64. Lidder PG, Sanders G, Whitehead E, Douie WJ, Mellor N, Lewis SJ, et al., Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery - a prospective, randomised, controlled trial. Ann R Coll Surg Engl 2007; 89: 418-421.
65. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P,. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604.
66. Devon KM, McLeod RS,. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery. Cochrane Database Syst Rev 2009; (1)CD007148.
67. Arora V, Velanovich V, Alarcon W,. Preoperative assessment of cardiac risk and perioperative cardiac management in noncardiac surgery. Int J Surg 2011; 9: 23-28.
68. Bakker EJ, Ravensbergen NJ, Poldermans D,. Perioperative cardiac evaluation, monitoring, and risk reduction strategies in noncardiac surgery patients. Curr Opin Crit Care 2011; 17: 409-415.
69. Poldermans D, Bax JJ, Boersma E, De HS, Eeckhout E, Fowkes G, et al., Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2010; 27: 92-137.
70. Mason KE, Davis LL,. Perioperative beta blockade in noncardiac surgery: a review of the literature. AANA J 2006; 74: 113-117.
71. Talati R, Reinhart KM, White CM, Phung OJ, Sedrakyan A, Kluger J, et al., Outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery: a meta-analysis. Ann Pharmacother 2009; 43: 1181-1188.
72. White CM, Talati R, Phung OJ, Baker WL, Reinhart K, Sedrakyan A, et al., Benefits and risks associated with beta-blocker prophylaxis in noncardiac surgery. Am J Health Syst Pharm 2010; 67: 523-530.
73. Ellenberger C, Tait G, Beattie WS,. Chronic beta blockade is associated with a better outcome after elective noncardiac surgery than acute beta blockade: a single-center propensity-matched cohort study. Anesthesiology 2011; 114: 817-823.
74. Lõpez-Sendõn J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, et al.,; Task Force On Beta-Blockers of the European Society of Cardiology. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 2004; 25: 1341-1362.
75. Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM,. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004; 291: 2092-2099.
76. Gerstein NS, Schulman PM, Gerstein WH, Petersen TR, Tawil I,. Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome. Ann Surg 2012; 255: 811-819.
77. Hulzebos EH, Helders PJ, Favié NJ, De Bie RA, Brutel de la, Riviere A, Van Meeteren NL,. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 2006; 296: 1851-1857.
78. Canedo J, Ricciardi K, Dasilva G, Rosen L, Weiss EG, Wexner SD,. Are postoperative complications more common following colon and rectal surgery in patients with chronic kidney disease? Colorectal Dis 2012; [Epub ahead of print].
79. Ackland GL, Moran N, Cone S, Grocott MP, Mythen MG,. Chronic kidney disease and postoperative morbidity after elective orthopedic surgery. Anesth Analg 2011; 112: 1375-1381.
80. de Goede B, Klitsie PJ, Lange JF, Metselaar HJ, Kazemier G,. Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review. Best Pract Res Clin Gastroenterol 2012; 26: 47-59.
81. Ziegler MA, Catto JA, Riggs TW, Gates ER, Grodsky MB, Wasvary HJ,. Risk factors for anastomotic leak and mortality in diabetic patients undergoing colectomy: analysis from a statewide surgical quality collaborative. Arch Surg 2012; 147: 600-605.
82. Stein KB, Snyder CF, Barone BB, Yeh HC, Peairs KS, Derr RL, et al., Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci 2010; 55: 1839-1851.
83. Braga M, Ljungqvist O, Soeters P, Fearon K, Weimann A, Bozzetti F,; ESPEN. ESPEN Guidelines on Parenteral Nutrition: surgery. Clin Nutr 2009; 28: 378-386.
84. Gupta A, Björnsson A, Fredriksson M, Hallböök O, Eintrei C,. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth 2011; 107: 164-170.
85. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ,. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 2008; 109: 180-187.
86. Tsui BC, Rashiq S, Schopflocher D, Murtha A, Broemling S, Pillay J, et al., Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 2010; 57: 107-112.
87. Fujioka N, Nguyen J, Chen C, Li Y, Pasrija T, Niehans G, et al., Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg 2011; 113: 1353-1364.
88. Lennon FE, Mirzapoiazova T, Mambetsariev B, Salgia R, Moss J, Singleton PA,. Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology 2012; 116: 857-867.
89. Akl EA, Vasireddi SR, Gunukula S, Yosuico VE, Barba M, Terrenato I, et al., Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst Rev 2011; (6)CD006466.
90. Thun MJ, Jacobs EJ, Patrono C,. The role of aspirin in cancer prevention. Nat Rev Clin Oncol 2012; 9: 259-267.
91. Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ, Song CW, et al., COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 2007; 97: 1523-1531.
92. Cook JW, Pierson LM, Herbert WG, Norton HJ, Fedor JM, Kiebzak GM, et al., The influence of patient strength, aerobic capacity and body composition upon outcomes after coronary artery bypass grafting. Thorac Cardiovasc Surg 2001; 49: 89-93.
93. Biccard BM,. Relationship between the inability to climb two flights of stairs and outcome after major non-cardiac surgery: implications for the pre-operative assessment of functional capacity. Anaesthesia 2005; 60: 588-593.
94. Carli F, Zavorsky GS,. Optimizing functional exercise capacity in the elderly surgical population. Curr Opin Clin Nutr Metab Care 2005; 8: 23-32.
95. Valkenet K, van de Port IG, Dronkers JJ, de Vries WR, Lindeman E, Backx FJ,. The effects of preoperative exercise therapy on postoperative outcome: a systematic review. Clin Rehabil 2011; 25: 99-111.
96. Mayo NE, Feldman L, Scott S, Zavorsky G, Kim do J, Charlebois P, et al., Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery. Surgery 2011; 150: 505-514.
97. Carli F, Charlebois P, Stein B, Feldman L, Zavorsky G, Kim DJ, et al., Randomized clinical trial of prehabilitation in colorectal surgery. Br J Surg 2010; 97: 1187-1197.
98. Carli F, Brown R, Kennepohl S,. Prehabilitation to enhance postoperative recovery for an octogenarian following robotic-assisted hysterectomy with endometrial cancer. Can J Anaesth 2012; 59: 779-784.
99. Li C, Carli F, Lee L, Charlebois P, Stein B, Liberman AS, et al., Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study. Surg Endosc 2012; [Epub ahead of print].
100. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, et al., Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006; 24: 3527-3534.
101. Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner GJ, Chan AT, Willett W, et al., Physical activity and male colorectal cancer survival. Arch Intern Med 2009; 169: 2102-2108.
102. Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, et al., Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 2006; 24: 3535-3541.
103. Soop M, Carlson GL, Hopkinson J, Clarke S, Thorell A, Nygren J, et al., Randomized clinical trial of the effects of immediate enteral nutrition on metabolic responses to major colorectal surgery in an enhanced recovery protocol. Br J Surg 2004; 91: 1138-1145.
104. Ryan AM, Reynolds JV, Healy L, Byrne M, Moore J, Brannelly N, et al., Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg 2009; 249: 355-363.
105. Zhang Y, Gu Y, Guo T, Li Y, Cai H,. Perioperative immunonutrition for gastrointestinal cancer: a systematic review of randomized controlled trials. Surg Oncol 2012; 21: e87-e95.
106. Ljungqvist O, Nygren J, Thorell A,. Modulation of post-operative insulin resistance by pre-operative carbohydrate loading. Proc Nutr Soc 2002; 61: 329-336.
107. Hausel J, Nygren J, Lagerkranser M, Hellstrom PM, Hammarqvist F, Almstrom C, et al., A carbohydrate-rich drink reduces preoperative discomfort in elective surgery patients. Anesth Analg 2001; 93: 1344-1350.
108. Helminen H, Viitanen H, Sajanti J,. Effect of preoperative intravenous carbohydrate loading on preoperative discomfort in elective surgery patients. Eur J Anaesthesiol 2009; 26: 123-127.
109. Noblett SE, Watson DS, Huong H, Davison B, Hainsworth PJ, Horgan AF,. Pre-operative oral carbohydrate loading in colorectal surgery: a randomized controlled trial. Colorectal Dis 2006; 8: 563-569.
110. Yuill KA, Richardson RA, Davidson HI, Garden OJ, Parks RW,. The administration of an oral carbohydrate-containing fluid prior to major elective upper-gastrointestinal surgery preserves skeletal muscle mass postoperatively - a randomised clinical trial. Clin Nutr 2005; 24: 32-37.
111. Bisgaard T, Kristiansen VB, Hjortsø NC, Jacobsen LS, Rosenberg J, Kehlet H,. Randomized clinical trial comparing an oral carbohydrate beverage with placebo before laparoscopic cholecystectomy. Br J Surg 2004; 91: 151-158.
112. Li L, Wang Z, Ying X, Tian J, Sun T, Yi K, et al., Preoperative carbohydrate loading for elective surgery: a systematic review and meta-analysis. Surg Today 2012; 42: 613-624.
113. Gustafsson UO, Nygren J, Thorell A, Soop M, Hellstrom PM, Ljungqvist O, et al., Pre-operative carbohydrate loading may be used in type 2 diabetes patients. Acta Anaesthesiol Scand 2008; 52: 946-951.
114. Breuer JP, von Dossow V, von Heymann C, Griesbach M, von Schickfus M, Mackh E, et al., Preoperative oral carbohydrate administration to ASA III-IV patients undergoing elective cardiac surgery. Anesth Analg 2006; 103: 1099-1108.
115. Salo M,. Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiol Scand 1992; 36: 201-220.
116. Shigemitsu Y, Saito T, Kinoshita T, Kobayashi M,. Influence of surgical stress on bactericidal activity of neutrophils and complications of infection in patients with esophageal cancer. J Surg Oncol 1992; 50: 90-97.
117. Veenhof AA, Vlug MS, van der Pas MH, Sietses C, van der Peet DL, de Lange-de Klerk ES, et al., Surgical stress response and postoperative immune function after laparoscopy or open surgery with fast track or standard perioperative care: a randomized trial. Ann Surg 2012; 255: 216-221.
118. Lacy AM, García-Valdecasas JC, Delgado S, Castells A, Taurá P, Piqué JM, et al., Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002; 359: 2224-2229.
119. Brivio F, Lissoni P, Perego MS, Lissoni A, Fumagalli L,. Abrogation of surgery-induced IL-6 hypersecretion by presurgical immunotherapy with IL-2 and its importance in the prevention of postoperative complications. J Biol Regul Homeost Agents 2001; 15: 370-374.
120. Brivio F, Lissoni P, Tisi E, Erba L, Barni S, Tancini G, et al., Effects of a preoperative therapy with interleukin-2 on surgery-induced lymphocytopenia in cancer patients. Oncology 1992; 49: 215-218.
121. van Dam RM, Hendry PO, Coolsen MM, Bemelmans MH, Lassen K, Revhaug A, et al.,; Enhanced Recovery After Surgery (ERAS) Group. Initial experience with a multimodal enhanced recovery programme in patients undergoing liver resection. Br J Surg 2008; 95: 969-975.
122. Basse L, Hjort, Jakobsen D, Billesbolle P, Werner M, Kehlet H,. A clinical pathway to accelerate recovery after colonic resection. Ann Surg 2000; 232: 51-57.
123. Basse L, Jakobsen DH, Bardram L, Billesbolle P, Lund C, Mogensen T, et al., Functional recovery after open versus laparoscopic colonic resection: a randomized, blinded study. Ann Surg 2005; 241: 416-423.
124. Majeed AW, Troy G, Nicholl JP, Smythe A, Reed MW, Stoddard CJ, et al., Randomised, prospective, single-blind comparison of laparoscopic versus small-incision cholecystectomy. Lancet 1996; 347: 989-994.
125. Lassen K, Høye A, Myrmel T,. Randomised trials in surgery: the burden of evidence. Rev Recent Clin Trials 2012; 7: 244-248.
126. Vlug MS, Wind J, Hollmann MW, Ubbink DT, Cense HA, Engel AF, et al.,; LAFA study group. Laparoscopy in combination with fast track multimodal management is the best perioperative strategy in patients undergoing colonic surgery: a randomized clinical trial (LAFA-study). Ann Surg 2011; 254: 868-875.
127. Maffezzini M, Campodonico F, Capponi G, Manuputty E, Gerbi G,. Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch. Surg Oncol 2012; 21: 191-195.
128. Yamada T, Hayashi T, Cho H, Yoshikawa T, Taniguchi H, Fukushima R, et al., Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery. Gastric Cancer 2012; 15: 34-41.
129. Cascales Campos PA, Gil Martínez J, Galindo Fernández PJ, Gil Gõmez E, Martínez Frutos IM, Parrilla Paricio P,. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer. Eur J Surg Oncol 2011; 37: 543-548.
130. Quality of life and clinical trials. Lancet 1995; 346: 1-2.
131. di Sebastiano P, Festa L, De Bonis A, Ciuffreda A, Valvano MR, Andriulli A, et al., A modified fast-track program for pancreatic surgery: a prospective single-center experience. Langenbecks Arch Surg 2011; 396: 345-351.
132. Munitiz V, Martinez-de-Haro LF, Ortiz A, Ruiz-de-Angulo D, Pastor P, Parrilla P,. Effectiveness of a written clinical pathway for enhanced recovery after transthoracic (Ivor Lewis) oesophagectomy. Br J Surg 2010; 97: 714-718.
133. Balzano G, Zerbi A, Braga M, Rocchetti S, Beneduce AA, Di Carlo V,. Fast-track recovery programme after pancreatico-duodenectomy reduces delayed gastric emptying. Br J Surg 2008; 95: 1387-1393.
134. Chughtai B, Abraham C, Finn D, Rosenberg S, Yarlagadda B, Perrotti M,. Fast track open partial nephrectomy: reduced postoperative length of stay with a goal-directed pathway does not compromise outcome. Adv Urol 2008; 507543.
135. Löhr G, Keller H, Kütscher J, Huber R,. [Fast-track rehabilitation after open aorto-iliac vascular procedures.] Zentralbl Chir 2008; 133: 344-348.
136. Mukherjee D,. 'Fast-track' abdominal aortic aneurysm repair. Vasc Endovascular Surg 2003; 37: 329-334.
137. Mukherjee D, Becker TE,. An update on the 'fast-track' abdominal aortic aneurysm repair. Int J Angiol 2008; 17: 93-97.
138. Spanjersberg WR, Reurings J, Keus F, van Laarhoven CJ,. Fast track surgery versus conventional recovery strategies for colorectal surgery. Cochrane Database Syst Rev 2011; (2)CD007635.
139. Eskicioglu C, Forbes SS, Aarts MA, Okrainec A, McLeod RS,. Enhanced recovery after surgery (ERAS) programs for patients having colorectal surgery: a meta-analysis of randomized trials. J Gastrointest Surg 2009; 13: 2321-2329.
140. Gouvas N, Tan E, Windsor A, Xynos E, Tekkis PP,. Fast-track vs standard care in colorectal surgery: a meta-analysis update. Int J Colorectal Dis 2009; 24: 1119-1131.
141. Franke RH, Kaul JD,. The Hawthorne experiments: first statistical interpretation. Am Soc Rev 1978; 43: 623-643.
142. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P,. The Hawthorne effect: a randomised, controlled trial. BMC Med Res Methodol 2007; 7: 30.
143. COLOR II Trial. http://www.facs.org/surgerynews/update/resection1011. html.